Cargando…
Pharmacokinetic Evaluation of Metabolic Drug Interactions between Repaglinide and Celecoxib by a Bioanalytical HPLC Method for Their Simultaneous Determination with Fluorescence Detection
Since diabetes mellitus and osteoarthritis are highly prevalent diseases, combinations of antidiabetic agents like repaglinide (REP) and non-steroidal anti-inflammatory drugs (NSAID) like celecoxib (CEL) could be commonly used in clinical practice. In this study, a simple and sensitive bioanalytical...
Autores principales: | Han, Dong-Gyun, Kwak, Jinsook, Seo, Seong-Wook, Kim, Ji-Min, Yoo, Jin-Wook, Jung, Yunjin, Lee, Yun-Hee, Kim, Min-Soo, Jung, Young-Suk, Yun, Hwayoung, Yoon, In-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723536/ https://www.ncbi.nlm.nih.gov/pubmed/31382371 http://dx.doi.org/10.3390/pharmaceutics11080382 |
Ejemplares similares
-
Assessment of Metabolic Interaction between Repaglinide and Quercetin via Mixed Inhibition in the Liver: In Vitro and In Vivo
por: Kim, Ji-Min, et al.
Publicado: (2021) -
Preparation and Evaluation of Amino Acid Conjugates of Celecoxib as Prodrugs to Improve the Pharmacokinetic and Therapeutic Properties of Celecoxib
por: Lee, Yonghyun, et al.
Publicado: (2020) -
Development of Spectrofluorimetric and HPLC Methods for In vitro Analysis of Repaglinide
por: Kaushal, N., et al.
Publicado: (2010) -
Celecoxib coupled to dextran via a glutamic acid linker yields a polymeric prodrug suitable for colonic delivery
por: Lee, Yonghyun, et al.
Publicado: (2015) -
Evaluation of glycine-bearing celecoxib derivatives as a colon-specific mutual prodrug acting on nuclear factor-κB, an anti-inflammatory target
por: Lee, Sunyoung, et al.
Publicado: (2015)